A Bennassar Vicens
A Bennassar Vicens
Clinical Lessons in Dermatology: Insights into Diagnosis, Management, and Professional Practice [0.03%]
皮肤病学的临床教学：诊断、治疗和职业实践的见解
J R Estela Cubells,W D James
J R Estela Cubells
Milia-like papules and ulcerated nodules in a man with Bartter syndrome [0.03%]
一名Bartter综合征男患者的类似ミリア的丘疹和溃疡性结节
E Carmona-Rocha,E Subiela,L Puig et al.
E Carmona-Rocha et al.
Dissecting Cellulitis Associated With Hormone Therapy in a Transgender Man [0.03%]
接受激素治疗的男性跨性别者的与细胞分解性皮炎相关的病例分析
J L Rodrigues Machado,M Domingos Almeida,R F Cortez de Almeida et al.
J L Rodrigues Machado et al.
Oral Roflumilast for Long-term Management of Behçet Spectrum Disorders: A Multicenter Observational Analysis [0.03%]
罗氟司特口服给药对Behcet病谱系疾病的长期管理作用：多中心观察分析
R Peñuelas Leal,J A Peñuelas Ruiz,Á González García et al.
R Peñuelas Leal et al.
Background: Recurrent aphthous stomatitis (RAS) and Behçet's disease (BD) are part of the Behçet spectrum disorders (BSD), sharing genetic traits and characterized by recurrent ulcers. No systemic treatment is approved ...
C Fidanzi,N Mori,V Dini et al.
C Fidanzi et al.
Long-Term Persistence, Safety and Efficacy Profile of Dupilumab in Atopic Dermatitis: A Real-World Retrospective Multicenter Study From Spain [0.03%]
dupilumab 治疗特应性皮炎长期疗效和安全性的西班牙全国多中心回顾性研究
J F Silvestre,S Santos-Alarcón,A Mengual-Sendra et al.
J F Silvestre et al.
Background: The safety and efficacy profile of dupilumab in the management of atopic dermatitis (AD) are established in clinical trials. However, long-term real-world persistence data in Spain are limited. ...
Use of an Alar Cartilage Chondromucosal Graft for Posterior Lamella Reconstruction in Full-Thickness Lower Eyelid Defects [0.03%]
应用鼻翼软骨黏膜皮片行下睑全层缺损后天壁重建术
E Samaniego González,E Pérez Díez,M Cuesta Lasso et al.
E Samaniego González et al.
Postimplantation breasts erythema, advancing in the knowledge of telangiectatic reticular erythema [0.03%]
植入后乳房红斑，.telangiectatic网状红斑的现状及展望
C Llamas-Segura,F J De La Torre-Gomar,F J Navarro Triviño et al.
C Llamas-Segura et al.
Sustained Efficacy of a Short Course of Upadacitinib in Atopic Dermatitis [0.03%]
Upadacitinib短期治疗对特应性皮炎疗效的持久性评估研究
S Córdoba,A Martínez-Lauwers Dolz,A A Garrido-Ríos et al.
S Córdoba et al.